Records containing: Rotavirus Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 1 Study to Evaluate the Safety and Immunogenicity of CDC-9 Inactivated Rotavirus Adjuvanted Vaccine for Intramuscular Administration in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase 1 Study to Evaluate the Safety and Immunogenicity of CDC-9 Inactivated Rotavirus Vaccine for Intradermal Administration by Microneedle Patch in Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-12-26SaniVac Trial: An Assessment of Oral Rotavirus Vaccine Performance Among Infants Enrolled in a Controlled Before-after Study in Low-income Neighbourhoods of Maputo, Mozambique
-
CLINICAL_TRIALS study record update · 2024-11-20A Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Subunit Rotavirus Vaccine in Healthy Infants Aged 6-12 Weeks and Healthy Toddlers Aged 7-71 Months
-
CLINICAL_TRIALS study record update · 2024-01-03Immunogenicity and Safety of the Inactivated Rotavirus Vaccine (Vero Cells) in Toddlers and Infants Aged From 2 to 71 Months: A Randomized, Double-blinded, Placebo-controlled Phase II Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-07-10A Phase II Randomized, Double Blind, Parallel Group Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine Administered at a High, Mid and Low Titre as a 3 Dose Neonate Schedule or Administered at a High Titre as a 3 Dose Infant Schedule.
-
CLINICAL_TRIALS study record update · 2022-03-17A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
-
CLINICAL_TRIALS study record update · 2021-09-08Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study of the Safety and Efficacy of the Vaccine for the Prevention of Pentavalent Live Rotavirus Infection in Healthy Subjects (Target Age of 18-45 Years Old).
-
CLINICAL_TRIALS study record update · 2020-03-31Randomized Evaluation of a Conditional Cash Transfer Program for Routine Immunizations of Infants in Nigeria
-
CLINICAL_TRIALS study record update · 2019-03-25An Open Label Study to Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® (Live Attenuated Rotavirus Vaccine) as a 3-dose Series in Healthy Infants Aged Between 6 Weeks and 8 Weeks in Vietnam
-
CLINICAL_TRIALS study record update · 2018-07-12Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
-
CLINICAL_TRIALS study record update · 2018-06-20An Open-label, Randomised, Comparative, Multi-centre Study of the Immunogenicity and Safety of the Concomitant Use of a Live Pentavalent Rotavirus Vaccine (RotaTeq®) and a Meningococcal Group C Conjugate (MCC) Vaccine in Healthy Infants
-
CLINICAL_TRIALS study record update · 2017-07-25The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
-
CLINICAL_TRIALS study record update · 2016-09-09Reactogenicity & Immunogenicity Study of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Co-administered With Either OPV or IPV in Healthy Infants (Approximately 5-10 Weeks Old) in South Africa
-
CLINICAL_TRIALS study record update · 2016-01-29Vaccine Effectiveness of RV1 in a Naïve Population
-
CLINICAL_TRIALS study record update · 2015-10-30Protocol for ROTATEQ™ Post-Marketing Surveillance
-
CLINICAL_TRIALS study record update · 2014-08-20Nested Case-control Analysis of the Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
-
CLINICAL_TRIALS study record update · 2013-04-25Evaluation of Rotavirus Vaccine Produced by Butantan Institute. Phase I - Safety, Tolerability and Immunogenicity Evaluation
-
CLINICAL_TRIALS study record update · 2011-06-01Surveillance of Rotavirus Gastroenteritis Among Children <5 Years of Age Visiting the Pediatric Emergency Room in Southern Israel
-
CLINICAL_TRIALS study record update · 2011-05-05Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
-
CLINICAL_TRIALS study record update · 2011-04-12Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants
-
CLINICAL_TRIALS study record update · 2010-09-09Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants
-
CLINICAL_TRIALS study record update · 2010-02-03Phase I/II, Randomized, Double-blind, Placebo-controlled, Staged Dosage Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] Administered to Healthy Indian Infants Concurrently With Other Standard EPI Vaccines
-
CLINICAL_TRIALS study record update · 2009-07-10Study of the Efficacy, Safety, and Immunogenicity of V260 at Expiry
-
CLINICAL_TRIALS study record update · 2008-07-02Reactogenicity and Immunogenicity of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Healthy Non-Malnourished Infants 8-12 Weeks of Age